Chrysos Corp Ltd
ASX:C79
Chrysos Corp Ltd
Chrysos Corp Ltd is a AU-based company operating in Commercial Services & Supplies industry. The company is headquartered in Adelaide, South Australia. The company went IPO on 2022-05-06. Chrysos Corporation Limited is an Australia-based company, which provides gold testing technology. The firm is focused to combine science and software to create technology solutions for the global mining industry. The firm's flagship product, PhotonAssay provides quantitative data to all the mining exploration companies. PhotonAssay is an environmentally friendly replacement for fire assay on-site and in the laboratory. Its technology causes excitation of atomic nuclei allowing enhanced analysis of gold, silver, copper and other elements. The firm operates in Australia, North America and Africa.
Chrysos Corp Ltd is a AU-based company operating in Commercial Services & Supplies industry. The company is headquartered in Adelaide, South Australia. The company went IPO on 2022-05-06. Chrysos Corporation Limited is an Australia-based company, which provides gold testing technology. The firm is focused to combine science and software to create technology solutions for the global mining industry. The firm's flagship product, PhotonAssay provides quantitative data to all the mining exploration companies. PhotonAssay is an environmentally friendly replacement for fire assay on-site and in the laboratory. Its technology causes excitation of atomic nuclei allowing enhanced analysis of gold, silver, copper and other elements. The firm operates in Australia, North America and Africa.
Strong Growth: Revenue grew by 49% year-on-year to $43.3 million, with EBITDA up 152% to $14.3 million and margin expanding to 33%.
Record Utilization: PhotonAssay sample volumes neared 1 million per month, with additional assay charges making up 27% of total revenue, up from 11% last year.
Contracting Momentum: 14 new lease agreements signed recently, bringing total contracted units to 72 and deployed units to 43, with deployments expected to accelerate.
Positive Profitability: Statutory NPAT reached $700,000, marking a transition to sustained profitability.
Financial Strength: Operating cash flow rose to $8.6 million, cash at $21.6 million, and debt facilities expanded to $200 million to support growth.
Guidance Tracking High: FY '26 revenue guidance reaffirmed at $80–90 million and EBITDA $20–27 million, with both metrics expected to come in at the upper end of these ranges.
Global Diversification: More than half of revenue now comes from outside APAC, and adoption with major labs and miners continues to build market share.
